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Abstract
Human oral exposure to aﬂatoxin B1 (AFB1) and fumonisin B1 (FB1) is associated with increased
hepatocellular carcinoma. Although evidence suggested interactive AFB1–FB1 hepatotoxicity, the
underlying mechanisms remain mostly unidentiﬁed. This work was aimed at evaluating the possible
AFB1–FB1 interplay to induce genetic and cell cycle toxicities in BRL-3A rat hepatocytes, reactive
oxygen species (ROS) involvement, and the AFB1 metabolizing pathways cytochrome P450 (CYP)
and arachidonic acid (ArAc) metabolism as ROS contributors. Flow cytometry of stained BRL-3A
hepatocytes was used to study the cell cycle (propidium iodide), ROS intracellular production
(DCFH-DA, HE, DAF-2 DA), and phospholipase A activity (staining with bis-BODIPY FL C11-PC).
The CYP1A activity was assessed by the 7-ethoxyresoruﬁn-O-deethylase (EROD) assay. Despite a
48-h exposure to FB1 (30 lM) not being genotoxic, the AFB1 (20 lM)-induced micronucleus fre-
quency was overcome by the AFB1–FB1 mixture (MIX), presumably showing toxin interaction. The
mycotoxins blocked G1/S-phase, but only MIX caused cell death. Overall, the oxidative stress led
these alterations as the pretreatment with N-acetyl-l-cysteine reduced such toxic eﬀects. While
AFB1 had a major input to the MIX pro-oxidant activity, with CYP and ArAc metabolism being
ROS contributors, these pathways were not involved in the FB1-elicited weak oxidative stress.
The MIX-induced micronucleus frequency in N-acetyl-L-cysteine pretreated cells was greater than
that caused by AFB1 without antioxidants, suggesting enhanced AFB1 direct genotoxicity probably
owing to the higher CYP activity and ArAc metabolism found in MIX. The metabolic pathways
modulation by AFB1–FB1 mixtures could raise its hepatocarcinogenic properties.
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1 | INTRODUCTION
Mycotoxins are fungal metabolites commonly found as low-level con-
taminants of food and feed, which aﬀect human and animal health.
Exposure to multiple toxic fungal metabolites through the consumption
of varied diets and of foodstuﬀs naturally contaminated with two or
more mycotoxins is a cause of great worldwide concern because their
individual toxicities may be modiﬁed in a synergistic, additive, or antag-
onistic manner when they co-occur.1
The isolation of Aspergillus ﬂavus and Fusarium verticillioides and
the co-occurrence of their main mycotoxins aﬂatoxin B1 (AFB1) and
fumonisin B1 (FB1) in the same substrate have frequently been
reported, especially in corn and rice, which represent the basic ingre-
dients of human and animal feeding in developing countries.2,3 The
interaction between AFB1 and FB1 is a matter of great interest because
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co-exposure to both mycotoxins has been associated with a high inci-
dence of hepatocellular carcinoma (HCC) in humans.4,5
AFB1 is one of the most relevant mycotoxins due to its high toxic
potential, being hepatotoxic, immunosuppressive, mutagenic, geno-
toxic, and carcinogenic in humans and animals.1,6 The toxicology of this
mycotoxin is intimately linked with its biotransformation to the highly
reactive AFB1-exo28,9-epoxide (AFBO), which produces a direct geno-
toxicity through the formation of adducts with the DNA,6 and to a
lesser extent the induction of oxidative stress, which is responsible
(probably among other causes) for the indirect genotoxicity of this aﬂa-
toxin.7 The predominant site of the AFB1 metabolism is the liver
through cytochrome P450 (CYP) activity, with CYP1A2 and 3A4 being
the major human CYP isoenzymes involved in AFBO formation.6 Sev-
eral studies carried out with liver microsomes of human, chicken, quail,
and turkey, and also on human lung cells and lymphoblasts exposed to
the concentrations of AFB1 commonly detected in food, have shown
that AFBO formation and DNA damage are mostly induced by
CYP1A2.8–12 Moreover, CYP activity itself is associated with electron
leakage, leading to reactive oxygen species (ROS) generation. Therefore
AFB1 bioactivation by this enzymatic complex would be expected to
cause ROS production. Among other AFB1-metabolizing enzymes are
found the lipoxygenases (LOX) and prostaglandin H synthase (PHS),
which are major components of the arachidonic acid (ArAc) metabolic
cascade.13 By this pathway, the highly reactive AFBO is formed when
peroxyl radicals, reactive intermediates formed by LOX and PHS during
the ArAc metabolism, epoxidize the AFB1 8,9-double bond.
14–16 ArAc
release from membranes is the limiting step in this metabolic cascade,
and can be triggered by the interaction of membrane-active agents
with the cell surface.17 Authors suggested that AFB1 can stimulate
ArAc release from membranes by inducing phospholipase A2 (PLA2)
activity, thereby enhancing its own bioactivation.14 Furthermore, bea-
cuse ROS are also generated as byproducts during the ArAc metabolite
oxidation by PHS and LOX, as well as through activating the ArAc-
induced NADPH oxidase,18 then in addition to the extra stimulus for
its own bioactivation, AFB1 might also increase ROS levels.
19 Although
the maximum hepatic LOX and PHS activities are minor compared with
those of CYP, the AFB1 oxidative metabolism by the former can occur
at low AFB1 concentrations, and therefore it may be important in terms
of human exposure through consumption of diets naturally contami-
nated with this aﬂatoxin.15
Consequently, variations in CYP activity, and to a lesser extent in
PLA2, LOX, and PHS activities, due to environmental factors or genetic
polymorphism, may be important determinants in the propensity of
populations to develop HCC after exposure to AFB1.
FB1 is the most toxic and abundant fumonisin being hepatotoxic,
neurotoxic, nephrotoxic, and immunotoxic in animals, and causing can-
cer in the esophagus and liver of humans and in the liver and kidney of
rodents.20 Its most recognized mechanism of action is by disrupting the
sphingolipid metabolism through inhibiting the ceramide synthase
enzyme, which leads to an alteration of the functionality of cell mem-
branes, cell growth, and cell injury.20 FB1 can also induce oxidative
stress, which may be responsible for indirect genotoxicity of this
toxin21; however, the mechanisms by which this toxin induces ROS
have only begun to be evaluated in recent years19,22 and are still not
clearly understood. In addition, the interaction of FB1 with biological
membranes may introduce perturbations in the environment, which
might aﬀect the activity of membrane-bound enzymes.23
Although FB1 is not metabolized by CYP, some authors have
shown that this toxin can modulate the activities and/or expression of
several CYP, such as 1A, 4A, 2B, 2C11, 2E, and 3A1, in rat liver as well
as in human and rat hepatic-derived cell lines.24–26 Therefore, FB1 pos-
sibly stimulates the AFB1 metabolism and hence increases its toxicity.
On the other hand, previous studies have reported that depending
on the sensitivities of the cell types and animal species, as well as the
routes and exposure levels, mycotoxins may have diverse cytotoxic
eﬀects. AFB1 was able to induce apoptosis and/or cell cycle arrest at
diﬀerent phases,27,28 and FB1 may cause apoptotic cell death, block
cell cycle progression and, in some contexts, inhibit apoptosis and stim-
ulate cell growth.29 These toxic eﬀects could be related to alteration of
the cellular oxidative state as well as to direct and/or indirect genotox-
icity induced by AFB1 and FB1, because increased ROS levels and DNA
damage may aﬀect the signaling pathways involved in cell cycle control
and cell survival.30,31
Studies with combined AFB1 and FB1 revealed that the mixture’s
main target organ was the liver, where the toxic eﬀects (such as
changes in liver weight and hepatic enzymes activities, and severe his-
topathological lesions) were more marked than those produced by the
individual toxins in rats, broiler chickens, rabbits, or trout.32–35 How-
ever, the type, complexity, and mechanisms of AFB1–FB1 interaction
need to be elucidated to clarify the adverse health and environmental
eﬀects of these toxin mixtures and to subsequently provide adequate
worldwide regulation concerning mycotoxins.
This work was aimed at evaluating the possible interaction of AFB1
and FB1 in inducing alteration of the cell cycle and genotoxicity in a rat
liver cell line, as well as at elucidating the contribution of oxidative stress
to these interactive hepatotoxic eﬀects and the involvement of relevant
biochemical pathways metabolizing AFB1, such as CYP and the ArAc
metabolism in ROS generation. The BRL-3A rat liver cells were used in
this study because it was demonstrated to be an appropriate tool for
testing hepatotoxicity mechanisms such as oxidative stress.36–38
2 | MATERIALS AND METHODS
2.1 | Chemicals
Dulbecco’s modiﬁed eagle medium (DMEM), heat-inactivated fetal
bovine serum (FBS), and bovine serum albumin (BSA) were purchased
from Gibco Laboratories (Buenos Aires, Argentina), with Bradford rea-
gent being obtained from Bio-Rad Laboratories (Buenos Aires, Argen-
tina). 1,1,3,3-Tetramethoxypropane (TEP), 2-thiobarbituric acid (TBA),
2,4-dinitrophenylhydrazine (DNPH), 20,70-dichlorodihydroﬂuorescein
diacetate (DCFH-DA), 4,5-diaminoﬂuorescein diacetate (DAF-2 DA), 7-
ethoxyresoruﬁn, AFB1, b-nicotinamide adenine dinucleotide 20-
phosphate reduced tetrasodium salt hydrate (NADPH), catalase, cipro-
ﬂoxacin (CIP), cytochalasin-B (Cyt-B), dexamethasone (DEX), dicumarol,
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dimethyl sulfoxide (DMSO), ethylene glycol-tetraacetic acid (EGTA),
FB1, gentamicin, guanidine hydrochloride, hydroethidine (HE), L-Gluta-
mine, N-acetyl-L-cysteine (NAC), propidium iodide (PI), resoruﬁn,
RNAse A, tetramethylrhodamineethyl ester (TMRE), trichloroacetic acid
(TCA), trypan blue, and trypsin were purchased from Sigma-Aldrich
(Buenos Aires, Argentina). L-a-Phosphatidylserine (PS) was provided by
Avanti Polar Lipids (Alabaster, AL, USA). Bis-BODIPY FL C11-PC was
purchased from Thermo Fisher Scientiﬁc (Buenos Aires, Argentina). All
other chemicals were provided by Sintorgan (Buenos Aires, Argentina)
at the highest analytical grade available.
2.2 | Cell culture
The BRL-3A immortal rat liver cell line was obtained from the American
Type Culture Collection (ATCC) (Manassas, VA, USA). This cell line was
cultured in DMEM supplemented with 10% FBS, 1% L-glutamine, and
50 lg/mL gentamicin at 378C in a humidiﬁed atmosphere with 5%
CO2, and split weekly with 0.5% trypsin/0.02% EDTANa2.
For all assays, the BRL-3A cells were plated in Petri dishes (10 cm
in diameter) or 24-well plates at a density of 7.2 3 105 cells/dish or 6
3 104 cells/well, respectively.
After 24 h, the cells were treated with 20 lM AFB1 dissolved in
DMSO (ﬁnal concentration: 8 mM), 30 lM FB1 dissolved in PBS, or
with an AFB1–FB1 mixture (20 lM AFB1130 lM FB1, MIX). The
choice of the higher concentration for FB1 related to AFB1 has been
made on the basis of the maximum permissible levels of these myco-
toxins in the international food standards and on the intestinal AFB1
and FB1 absorption (about 100 and 4%, respectively) after oral adminis-
tration to rats. Moreover, the doses were selected on the basis of the
literature data and previous studies.19,21,25,37
2.3 | Cell viability
The cell viability was studied after 48 h of incubation with the myco-
toxins or DMSO (0.07–0.21%, v/v), using the trypan blue exclusion and
MTT tests.19
2.4 | Micronucleus (MN) assay
This assay was performed as previously informed by Theumer et al.21 In
brief, the BRL-3A cells were exposed to the toxins for 24 h, and then
Cyt-B (3 lg/mL) was added and the cells were incubated for a further
24 h. To assess the ROS involvement in DNA damage, the cells were
pretreated with the antioxidant NAC 5 mM for 0.5 h; then the mycotox-
ins were added and the incubation maintained for 48 h. Afterward, the
cells were harvested and ﬁxed for 10 min in absolute methanol, prior to
being stained with Hoechst dye. One thousand binucleated cells were
analyzed by ﬂuorescence microscopy using an inverted microscope
(Nikon, Germany) and MN frequencies were calculated.
2.5 | Cell cycle analysis
The cell cycle was studied by staining with PI and ﬂow cytometric
determination.39 Brieﬂy, the BRL-3A cells were pretreated with or
without 5 mM NAC for 0.5 h, to assess ROS involvement in cell cycle
alteration. Then, the mycotoxins were added, and after 48 h of incuba-
tion, the cells were ﬁxed in 70% ice-cold ethanol overnight at 48C,
before being incubated with 50 lg/mL PI and 100 lg/mL RNase A for
0.5 h at 378C in the dark. Cells were analyzed using a ﬂow cytometer
(FACSCantoII, Becton Dickinson) and 50,000 events were acquired for
each sample (excitation at 488 nm, emission at 600 nm). The cellular
DNA proﬁle was evaluated using histograms, and the cell percentages
of the sub G0/G1 (dead cells), G0/G1, S, and G2/M phases were
obtained using software from Verity ModFit 3.1 (Portland, OR, USA).
2.6 | p53 expression
It was assessed by Western blot. BRL-3A cell protein extracts were
prepared in sample buﬀer containing 60 mM Tris–HCl pH 6.8, 10%
glycerol, 2% sodium dodecyl sulphate, 1% 2-b-mercaptoethanol, and
0.002% bromophenol blue. Then, the protein samples were separated
on a 10% SDS-polyacrylamide gel, and transferred to a nitrocellulose
membrane (Amersham Bioscience, Amersahm place, Little Chalfont,
UK). Ponceau staining (0.2% Ponceau, 3% tricloroactic acid, 3% sulfosa-
licilic acid) was used to verify protein transference from gel to nitrocel-
lulose membrane. Nonspeciﬁc binding was blocked with 5% nonfat
milk in Tris–HCl saline buﬀer containing 0.01% Tween 20, pH 8.3
(TBS-T) for 1 h at room temperature. The membrane was subsequently
incubated with anti-p53 and anti-b-actin (used as loading control) anti-
bodies (Santa Cruz Biotechnology, CA) diluted in 5% nonfat milk in
TBS-T at 48C overnight, washed three times with TBS-T, and then incu-
bated with secondary horseradish peroxidase-conjugated antibodies
(Santa Cruz Biotechnology, CA) in TBS-T for 1.5 h at room tempera-
ture. The speciﬁc band was revealed by a chemiluminescence reaction
(Amersham Biosciences) with autoradiographic or maximum perform-
ance light ﬁlms (Kodak, Rochester, NY) and quantiﬁed by densitometric
analysis using image software (Gel-Pro Analyzer version 3.1).
2.7 | Mitochondrial membrane potential (DWm) assay
To evaluate changes in DWm, the BRL-3A cells were exposed to the
mycotoxins for 24 h, and then incubation was continued with 50 nM
of the ﬂuorescent probe TMRE for another 0.5 h at 378C. Afterwards,
cells were washed and resuspended in PBS, and the TMRE ﬂuores-
cence was measured by ﬂow cytometry using exitation and emission
wavelengths of 488 and 574 nm, respectively (20,000 events were
acquired for each sample). Results were expressed as the relative
TMRE mean ﬂuorescence intensity (fold) in treated cells with respect
to the untreated ones.
2.8 | Detection of biomolecular oxidative damage
2.8.1 | Proteins
Protein oxidation was determined by measuring the levels of the car-
bonyl groups, using the spectrophotometric DNPH method as previ-
ously described.19 Brieﬂy, after treatments with the mycotoxins for
48 h, the BRL-3A cells were lysed with 50 mM HEPES buﬀer (pH 7.4)
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containing protease inhibitors. Then, the samples were divided into
two equal portions (containing 0.5–1 mg of protein, assessed by the
Bradford method), and treated for 1 h with either 10 mM DNPH in
2 M HCl or with 2 M HCl alone. Each portion was washed with etha-
nol:ethyl acetate (1:1) and dissolved with 6 M guanidine hydrochloride.
The carbonyl levels were obtained from the diﬀerence in absorbance
at 375 nm (e522,000 M/cm) between the DNPH-treated and HCl-
treated portions, and expressed as nmol of carbonyls/mg protein.
2.8.2 | Lipids
The malondialdehide (MDA) level, a widely used lipid peroxidation
marker, was selectively measured by using the TBA test, with subse-
quent separation and quantiﬁcation of the MDA–TBA adducts by
HPLC.19 In brief, after exposure to the mycotoxins for 48 h, the BRL-
3A cells were lysed with 50 mM HEPES buﬀer (pH 7.4), and the pro-
teins of the lysates were measured by the Bradford method and pre-
cipitated with 5% trichloroacetic acid (TCA).
Samples were treated with 0.25% TBA in 0.5 M HCl for 45 min at
908C, and then ice-cooled and analyzed by HPLC on a C18 column
with UV detection (532 nm). The mobile phase used was 50 mM
KH2PO4 (pH 6.0):methanol (65:35), at a ﬂow rate of 1 mL/min. The
MDA levels were calculated from a calibration curve based on the acid
hydrolysis of TEP and the reaction with TBA. All results were
expressed as nmol MDA/mg protein.
2.9 | Measurement of catalase (CAT) activity
This antioxidant enzyme catalyzes the decomposition of hydrogen per-
oxide (H2O2) to water and O2. Brieﬂy, after treatments with the myco-
toxins for 24 or 48 h, the BRL-3A cells were lysed with 50 mM HEPES
buﬀer (pH 7.4) containing protease inhibitors. Then, cell debris was
removed by centrifugation (11,000g 3 10 min at 48C), and the proteins
of the lysates were measured by the Bradford method. CAT activity
was measured using the method of Aebi,40 with 10 lL of each super-
natant being mixed with 50 lL of PBS and 40 lL of 0.2 M H2O2 per
well in a 96-well plate (ﬂat bottom). Finally, 200 lL of 0.2 M potassium
dichromate in glacial acetic acid were added to each well and this was
maintained for 20 min at 378C in the dark. The evaluation of enzyme
activity was performed by interpolating the absorbance of the samples
at 570 nm (determined using the Bio-Rad Benchmark Microplate
Reader) on a calibration curve, made with diﬀerent concentrations of
pure CAT plus the reagents mentioned above. The results were
expressed as the relative catalase activity (fold) in treated cells with
respect to the untreated ones.
2.10 | Detection of ROS and reactive nitrogen species
(RNS)
The intracellular production of total ROS, superoxide radical anion
(O·22 ), and RNS was determined using the probes DCFH-DA, HE, and
DAF-2 DA, respectively. Brieﬂy, the BRL-3A cells were exposed to the
mycotoxins for 0.5, 4, or 24 h, and then incubation was continued with
10 lM DCFH-DA, 2 lM HE, or 10 lM DAF-2 DA for another 20 min.
Afterward, cells were washed and resuspended in PBS, and the ﬂuores-
cence of the oxidized probes DCF, 2-OH-E1, and DAF-2T, respec-
tively, was measured by ﬂow cytometry (20,000 events were acquired
for each sample; with excitation at 488 nm and emission at 528, 580,
and 538 nm for DCF, 2-OH-E1, and DAF-2T, respectively). Results
were expressed as the relative mean ﬂuorescence intensity (fold) in
treated cells with respect to the untreated ones, and as the average
percentage of positive cells obtained from a marker used as cutoﬀ to
compare the eﬀects, chosen based on the histogram of unstained cells.
To assess the contribution of the CYP monooxygenase system and
the ArAc metabolism to ROS formation, the BRL-3A cells were prein-
cubated for 0.5 h with or without 50 lM CIP (inhibitor of main CYP
isoenzymes metabolizing AFB1, 1A, and 3A)
41 or 0.01 lM DEX (PLA2
inhibitor).42 Then, the mycotoxins were added to the medium, and the
cells were maintained in the culture for 24 h and treated with 10 lM
DCFH-DA, as explained above.
2.11 | Measurement of PLA activity
The PLA activity was monitored using a synthetic ﬂuorogenic phospho-
lipid molecule bis-BODIPY FL C11-PC, which is cleaved by PLA result-
ing in unquenching and green ﬂuorescent emission. Brieﬂy, the probe
(1 mg/mL dry chloroform) was combined with PS (2 mg/mL dry chloro-
form) in a molar ratio 1:9, and then, the organic solvent was evaporated
under a stream of nitrogen. After, the dried lipid ﬁlm was rehydrated
with 1 mL PBS and sonicated using a probe sonicator for 30 min (90 W
power) on ice, to obtain small unilamellar liposomes. Promptly, the
labeled liposomes and BRL-3A cells were mixed at a ratio of 0.2 lg
probe/5 3 105 cells in 50 lL PBS containing 0.1% BSA and incubated
for 60 min a 378C, to incorporate the probe into the plasma membrane
inner leaﬂet via fusion with labeled PS liposomes. Then, the cells were
washed three times in PBS and resuspended in PBS containing 1.5 mM
Ca21/1.5 mM Mg21, pH 7.3, for 10 min at 378C. At the end of the
incubation period, the reaction was stopped by adding an ice-cold solu-
tion containing 2 mM EGTA, 150 mM NaCl, and 1% BSA-free fatty
acid. Cells were analyzed using a ﬂow cytometer and 20,000 events
were acquired for each sample (excitation at 488 nm and emission at
530 nm). Results were expressed as the relative bis-BODIPY FL C11-
PC mean intensity of ﬂuorescence (fold) in treated cells with respect to
the untreated ones.
2.12 | Assessment of the CYP1A activity
The 7-ethoxyresoruﬁn-O-deethylase (EROD) assay was used to esti-
mate the activity of CYP1A.25 Brieﬂy, the BRL-3A cells exposed to the
treatments with mycotoxins for 24 h were washed with PBS (pH 7.5)
and frozen in liquid nitrogen. Then, a reaction mixture containing buﬀer
Na2HPO4 (50 mM, pH 8.0), 7-ethoxyresoruﬁn (1.25 lM), dicumarol
(20 lM), and NaDPH (0.5 mM) was added to each sample. The resoru-
ﬁn product formation was measured at 532 nm excitation and 590 nm
emission wavelengths in a Multi-Mode Microplate Reader Sinergy HT
(BioTek Instruments, Winooski, VT, USA). Resoruﬁn concentrations
were determined from a calibration curve in the range of 0–50 pmol of
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resoruﬁn standard, and then were normalized per milligram protein
from the BSA standard curve as determined by the Bradford method.
EROD activity was expressed as pmol resoruﬁn/mg protein/min.
2.13 | Statistical analysis
Data from these studies were obtained from a minimum of three inde-
pendent experiments (n56, for each treatment), and assessed by a
one-way ANOVA followed by Bonferroni’s post hoc test using Graph-
PadInStat software version 3.01 (La Jolla, CA, USA). Results were
expressed as the mean6 standard error of the mean (SEM), with diﬀer-
ences being considered signiﬁcant at the P<0.05 level.
3 | RESULTS
3.1 | Cell viability
The trypan blue exclusion and MTT tests showed that the cell viability
at 48 h was in the range 80–90% depending on the treatment with
mycotoxins and was above 90% in the control cells (data not shown).
3.2 | DNA damage induced by AFB1 and FB1
Among the available genotoxicity tests, MN assay is recognized due to
its robustness, sensitivity, and statistical power to evaluate DNA
breaks, which can be considered hallmarks of mutagenicity.43 The abil-
ity of individual and combined mycotoxins to induce DNA damage in
BRL-3A cells was tested at 48 h and the presence of MN was evi-
denced by Hoechst staining (Figure 1). The incubation of cells with
AFB1 and MIX signiﬁcantly raised the frequency of MN compared to
control (the changes were higher than three- and fourfold, respec-
tively), whereas exposure to FB1 did not produce signiﬁcant changes in
the basal DNA damage observed in the absence of toxins. There was a
higher percentage of MN in cells treated with MIX, compared to the
AFB1 or FB1 treatments. Furthermore, the eﬀect caused by AFB1 alone
or combined with FB1 was partially inhibited by the antioxidant NAC
(P<0.05 in both cases).
3.3 | Cell cycle arrest induced by AFB1 and FB1
As it is widely known that the DNA damage is often accompanied by
cell cycle arrest, the AFB1 and FB1 eﬀects on the cell cycle were tested
in the BRL-3A cells, with results of these experiments being shown in
FIGURE 1 DNA damage induced by individual and combined AFB1 and FB1 in BRL-3A cells at 48 h: involvement of oxidative stress. The
results are expressed as % MN. Lowercase letters indicate diﬀerences from the corresponding control (cP<0.001). Capital letters denote
the diﬀerences between the treatments with and without NAC (AP<0.05). (Right) Fluorescent micrograph of binucleated cells after treat-
ment with MIX and cytochalasin-B, showing MN with Hoechst stain
TABLE 1 Cell cycle alteration induced by individual and combined
AFB1 and FB1 in the BRL-3A cells at 48 h: involvement of oxidative
stress
Treatment NAC G0/G1 S G2/M
Control 2 65.286 0.22 30.676 0.40 4.1060.15
1 64.006 0.40 32.006 0.35 4.3060.19
AFB1 2 69.856 0.39*** 26.646 0.46*** 3.4060.23
1 67.506 0.28***# 29.006 0.40**# 3.7060.17
FB1 2 69.456 0.39** 27.256 0.53**a 3.5060.20
1 68.006 0.57** 28.606 0.50** 3.6060.15
MIX 2 71.006 0.60*** 25.006 0.49*** 3.4060.19
1 67.006 0.46**## 28.506 0.46**## 3.8060.22
Results are expressed as average cell percentage in each phase6 SEM.
*Diﬀerence from the corresponding control (**P<0.01, ***P< 0.001).
#Diﬀerence between the treatments with and without NAC (#P<0.05,
##P<0.01). Letters indicate diﬀerences between the MIX and mycotoxins
alone (aP<0.05).
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Table 1. The percentages of cells in the G0–G1 and S phases were
either increased or decreased, respectively, after treatments for 48 h
with MIX, AFB1 (P<0.001 in both cases) or FB1 (P<0.05). Neverthe-
less, there were no signiﬁcant diﬀerences among the treatments with
the mycotoxins, except for the lower proportion of cells in the S phase
found in MIX compared to FB1 (P<0.05).
To assess whether DNA oxidative damage had contributed to the
minor G1–S phase transition, the cells were pretreated with NAC, and
it was found that this antioxidant signiﬁcantly decreased the G1-phase
arrest caused by AFB1 (P<0.05) and MIX (P<0.01).
3.4 | Cell death induced by AFB1 and FB1
A decrease in DNA content was used as cell death marker, which was
measured by ﬂow cytometry in the BRL-3A cells treated with mycotox-
ins for 48 h. The ﬁndings of these assays are depicted in Figure 2,
which shows that MIX was the only treatment that signiﬁcantly
increased the percentage of dead cells, with respect to either the con-
trol or the mycotoxins alone (P<0.001 in all cases). Furthermore, pre-
treatment with NAC prevented partly the cell death induced by MIX
(P<0.05).
Morphological evaluation of cell nuclei showed that the cell death
induced by MIX was mainly apoptotic (Figure 2).
3.5 | p53 expression induced by AFB1 and FB1
Immunoblotting assay showed that the p53 protein levels in BRL-3A
cells increased after 24 h of treatment with mycotoxins individually
and especially in combination. Moreover, the higher p53 expressions
induced by AFB1 and MIX were partially prevented when the cells
were preincubated with NAC (Figure 3).
3.6 | Mitochondrial membrane depolarization induced
by AFB1 and FB1
The eﬀect of AFB1 and FB1 on the DWm was measured by ﬂow cytom-
etry in the BRL-3A cells treated with mycotoxins for 24 h. The results
of these assays (Figure 4) show that the TMRE ﬂuorescence intensity
FIGURE 2 Cell death induced by individual and combined AFB1 and FB1 in BRL-3A cells at 48 h: involvement of oxidative stress. The
results are expressed as % dead cells. Lowercase letters indicate the diﬀerences from the corresponding control (aP<0.05, cP<0.001). Cap-
ital letters denote the diﬀerences between the treatments with and without NAC (AP<0.05). (Right) Fluorescent micrograph of cells treated
with MIX, showing apoptotic cell death with Hoechst stain, and the corresponding bright ﬁeld image
FIGURE 3 p53 protein level induced by individual and combined
AFB1 and FB1 in BRL-3A cells at 24 h: involvement of oxidative
stress. The p53 expression was normalized with the b-actin expres-
sion, and the results are expressed as the relative p53 protein level
(fold) in treated cells with respect to the untreated ones, with low-
ercase letters indicating diﬀerences from the corresponding control
(cP<0.001), and capital letters denoting diﬀerences between the
treatments with and without NAC (AP<0.05). A representative blot is
shown
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was decreased in MIX-treated cells (P<0.05), concordantly with the
ﬁndings in the DNA content analysis, hence conﬁrming the induction
of apoptotic cell death. Moreover, pretreatment with NAC prevented
the mitochondrial membrane depolarization produced by MIX
(P<0.05).
3.7 | Biomolecular oxidative damage induced by AFB1
and FB1
The protein carbonyl and MDA levels were assessed in BRL-3A cells to
estimate the extent of the oxidative damage induced by exposure to
the mycotoxins for 48 h (Figure 5) in proteins and lipids, respectively.
MIX was the only treatment that signiﬁcantly increased the car-
bonyl levels with respect to control and the mycotoxins alone (Figure
5A). However, exposure of the cells to AFB1 and FB1, individually or in
combination, signiﬁcantly raised MDA formation with regard to the
control (Figure 5B) with the lipid peroxidation being higher in the cells
treated with MIX compared to that with the mycotoxins alone.
3.8 | Eﬀects of AFB1 and FB1 on CAT activity
CAT biological activity was measured as an oxidative stress biomarker
in the BRL-3A cells exposed to the mycotoxins for 24 and 48 h, with
the results being shown in Figure 6.
Although the incubation of the cells with AFB1 and FB1 alone did
not produce any major changes in the CAT activity, MIX signiﬁcantly
raised this marker of oxidative status compared to control and myco-
toxins individually at both end points tested (P<0.001 in all cases).
3.9 | Intracellular RNS generation induced by AFB1
and FB1
The ability of mycotoxins to induce intracellular RNS (nitric oxide and
its degradation products, such as nitrosonium cation, peroxynitrite
anion, and nitrogen dioxide) in BRL-3A cells was tested at 24 h using
the DAF-2 DA probe. In Figure 7A, representative histograms of DAF-
2T ﬂuorescence intensity are depicted, which display the percentages
of positive cells from untreated BRL-3A cells and those incubated with
the mycotoxins. In addition, the average percentages for each treat-
ment were calculated from these results.
FIGURE 4 Changes in mitochondrial membrane potential induced
by individual and combined AFB1 and FB1 in BRL-3A cells at 24 h:
involvement of oxidative stress. The results are expressed as rela-
tive TMRE-ﬂuorescence intensity (fold) in treated cells, with
respect to untreated ones. Lowercase letters indicate diﬀerences
from the corresponding control (aP<0.05), and capital letters
denote diﬀerences between the treatments with and without NAC
(AP<0.05)
FIGURE 5 Carbonyl (A) and MDA (B) levels induced by individual
and combined AFB1 and FB1 in BRL-3A cells at 48 h. The results
are expressed as nmol carbonyls or MDA/mg of protein. Letters
indicate diﬀerences from the control (aP<0.05, cP<0.001)
FIGURE 6 Catalase activity induced by individual and combined
AFB1 and FB1 in BRL-3A cells at 24 and 48 h. The results are
expressed as the relative catalase activity (fold) in treated cells
with respect to the untreated ones. Letters indicate diﬀerences
from the corresponding control (cP<0.001)
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In a similar manner, AFB1 and MIX signiﬁcantly increased the per-
centage of DAF-2T1 cells (Figure 7A, P<0.001 for both cases) and rel-
ative DAF-2T ﬂuorescence intensities compared to control (Figure 7B).
However, FB1 alone did not modify either of these parameters (Figure
7A,B).
3.10 | Intracellular O·22 generation induced by AFB1
and FB1
The O·22 levels were measured using the HE probe in BRL-3A cells
exposed to the mycotoxins for 0.5 and 4 h. When BRL-3A cells were
incubated for 0.5 h with toxins, the O·22 levels remained unchanged
with respect to control (data not shown), whereas O·22 generation was
modulated in cells cultured 4 h with the mycotoxins.
In Figure 8A, representative histograms of HE ﬂuorescence inten-
sity for each treatment are shown, which display the average percent-
age of positive cells for each experimental condition at 4 h. O·22
generation increased after MIX, as depicted by the signiﬁcant rises in
the percentage of HE1 cells (Figure 8A) and in the HE ﬂuorescence
intensity (Figure 8B), with respect to control (P<0.001 for both param-
eters) or the mycotoxins individually (P<0.01 for the two toxins and
both parameters). A tendency to higher values than control, although
lacking statistical signiﬁcance, was also induced by AFB1 and FB1
alone.
3.11 | Intracellular total ROS generation induced by
AFB1 and FB1
The capacity of mycotoxins to induce intracellular ROS in the BRL-3A
cells was studied at 0.5, 4, and 24 h of incubation by using the DCFH-
DA probe. Representative histograms of DCF ﬂuorescence intensity for
each treatment are shown in Figure 9A, where the average percentage of
positive cells for each experimental condition at 24 h can be observed.
The 24 h exposure of the BRL-3A cells to AFB1, FB1 and MIX
resulted in signiﬁcant increases in the proportion of DCF1 cells (Figure
9A, P<0.01, P<0.05, P<0.001, respectively) and in the relative DCF
FIGURE 7 The total RNS level induced by individual and combined AFB1 and FB1 in BRL-3A cells at 24 h. A, Representative histograms of
DAF-2T ﬂuorescence intensity showing percentages of DAF-2T1 cells, and B, relative DAF-2T -ﬂuorescence intensity (fold) in treated cells
with respect to untreated ones. Letters indicate the diﬀerences from the control (bP<0.01, cP<0.001)
FIGURE 8 The O·22 level induced by individual and combined AFB1 and FB1 in BRL-3A cells at 4 h. Representative histograms of HE ﬂuo-
rescence intensity showing percentages of HE1 cells (A), and relative HE-ﬂuorescence intensity (fold) in treated cells with respect to
untreated ones (B). Letters indicate the diﬀerences from the control (cP<0.001)
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ﬂuorescence intensity (Figure 9B) compared to control, with ROS levels
being higher in the cells treated with MIX compared to the individual
mycotoxins (P<0.01 for AFB1 and P<0.001 for FB1, for both parame-
ters). However, when the BRL-3A cells were incubated with mycotox-
ins for shorter times, no diﬀerences in the ROS levels were observed
with respect to control, except for MIX, which resulted in an enhanced
ROS accumulation at 4 h, as depicted by the signiﬁcant rise in the DCF
ﬂuorescence intensity at this end point (Figure 9B, P<0.01).
3.12 | Biochemical pathways involved in the ROS
generation induced by AFB1 and FB1
Using the DCFH-DA probe, the participation of the ArAc metabolism
and the CYP monooxygenase system in the ROS generation was
assessed by preincubating the BRL-3A cells with DEX (PLA2 inhibitor)
or CIP (CYP 1A and 3A inhibitor), respectively, prior to a further 24 h
incubation of the cells with the mycotoxins (Figure 10). AFB1 increased
the DCF ﬂuorescence intensity 0.67-fold change with respect to the
control and this raise was decreased in 0.25- and 0.32-fold changes by
DEX and CIP, respectively. In contrast, these blocking substances had
scarce eﬀects on the DCF ﬂuorescence intensity increased by FB1,
indicating that the ROS sources studied did not signiﬁcantly contribute
to the higher oxidative status induced by this fumonisin. Moreover,
both inhibitors signiﬁcantly prevented the ROS increase induced by
MIX, with the DCF ﬂuorescence intensity elicited by MIX1CIP being
signiﬁcantly lower (P<0.05) with regard to that induced by
MIX1DEX, and suggesting a greater contribution from the CYP sys-
tem to ROS accumulation. In other words, MIX caused a rise in the
DCF ﬂuorescence intensity of 1.3-fold change relative to control, with
this increment being reduced by 0.49- and 0.81-fold changes by DEX
and CIP, respectively. These results strongly suggest that the ArAc
metabolism and CYP activity signiﬁcantly contributed to the ROS
increase elicited by AFB1 and MIX, pointing out these metabolic path-
ways as major ROS sources stimulated by the AFB1-containing
treatments.
3.13 | Eﬀects of AFB1 and FB1 on PLA biological
activity
PLA biological activity was measured by ﬂow cytometry in the BRL-3A
cells exposed to the mycotoxins for 24 h, with representative histo-
grams of bis-BODIPY FL C11-PC ﬂuorescence and the relative mean
intensity of ﬂuorescence (MIF) of this probe for each treatment being
shown in Figure 11A,B, respectively. AFB1 and MIX signiﬁcantly
increased the bis-BODIPY FL C11-PC MIF respect to the control (P
<0.001, in both cases), with MIX-induced PLA activity being
FIGURE 9 The total ROS level induced by individual and combined AFB1 and FB1 in BRL-3A cells at 0.5, 4, and 24 h. Representative histo-
grams of DCF ﬂuorescence intensity from cells incubated or not with the mycotoxins for 24 h, showing the percentages of DCF 1 cells (A);
and relative DCF ﬂuorescence intensities (fold) in treated cells, with respect to untreated ones (B). Letters indicate the diﬀerences from the
control (aP<0.05, bP<0.01, cP<0.001)
FIGURE 10 Induction of the ArAc metabolism and the CYP
monooxygenase system by individual and combined AFB1 and FB1
in BRL-3A cells at 24 h. The results are expressed as the relative
DCF ﬂuorescence intensity (fold) average in treated cells, with
respect to untreated ones. Letters indicate the diﬀerences from the
corresponding control (aP<0.05, bP<0.01, cP<0.001)
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signiﬁcantly higher than the one stimulated by AFB1 (P<0.05) and FB1
(P<0.001) individually.
3.14 | Eﬀects of AFB1 and FB1 on CYP1A activity
While the exposure of BRL-3A cells to AFB1 for 24 h resulted in a sig-
niﬁcant increase of EROD activity (P<0.05), FB1 did not modify this
parameter. However, when cells were cultured with the mixture of
both mycotoxins, there was a signiﬁcant increase in EROD activity
with respect to control (P<0.001) and individual mycotoxins (P<0.05
for AFB1; P<0.001 for FB1) (Figure 12).
4 | DISCUSSION
In this work, it was found that the AFB1–FB1 mixture had higher geno-
toxic, mutagenic, and cytotoxic eﬀects than those caused by the toxins
individually. Although FB1 did not signiﬁcantly modify the MN fre-
quency, the genotoxicity resulting from AFB1 in the BRL-3A cells was
increased by its combination with the former toxin, suggesting the
probable occurrence of a synergistic interaction between them that
could confer a higher hepatocarcinogenic potential to the mixture.
These results are in agreement with ﬁndings from in vivo studies, which
showed that the simultaneous subchronic oral administration of AFB1
and FB1 to rats produced more liver cancer initiation than the exposure
to the individual mycotoxins.44
AFB1 and FB1 individually cause excessive ROS forma-
tion,19,21,29,45 that could readily attack DNA and generate a variety of
lesions, such as oxidized DNA bases, abasic sites, and DNA strand
breaks, leading ultimately to genomic instability.46 Hence, we explored
the probable involvement of ROS in the chromosome aberrations
induced by these mycotoxins, after preincubating the BRL-3A cells
with the thiol-containing antioxidant NAC, which has been widely used
to investigate the role of ROS in numerous biological and pathological
processes, for its free-radical direct scavenging activity and for being a
precursor of L-cysteine and reduced glutathione.47,48 It was found that
NAC partially reduced the percentage of MN, and therefore the muta-
genicity of the AFB1–FB1 mixture, indicating that the genetic damage
was produced at least in part by DNA oxidation, which has been previ-
ously proposed as an indirect toxicity mechanism exerted by these tox-
ins individually.21,45 However, due to the nonoxidative genotoxicity
found in cells incubated with both toxins being greater than that
observed in cells treated only with AFB1, this may be indicating an
increased direct genotoxic activity (adduct formation) of the mixture,
probably as a result of the major activation of CYP and the ArAc
metabolism, which are the biochemical pathways involved in AFB1
biotransformation.13–16 The results of this study are in agreement with
those from a previous investigation, where the combination of AFB1
and FB1 resulted in increased CYP activity in H4IIE rat hepatoma cells
by inducing speciﬁcally cyp1A expression and CYP1A activity, respect
to the individual toxins.25 Although some studies have shown that FB1
clastogenicity and genotoxicity were associated with an indirect mech-
anism involving oxidative damage to the human-derived hepatoma
(HepG2) cells, spleen mononuclear cells, and hepatocytes from
rat,19,21,49 FB1 did not increase chromosomal aberrations in BRL-3A
cells, even though the toxin worsened the cellular oxidative status. The
lack of changes in the MN frequency in cells exposed to FB1 could in
FIGURE 11 The PLA activity induced by individual and combined AFB1 and FB1 in BRL-3A cells at 24 h. Representative histograms of bis-
BODIPY FL C11-PC ﬂuorescence (A), and relative mean ﬂuorescence intensity (fold) of this probe in treated cells, with respect to untreated
ones (B). Letters indicate the diﬀerences from the control (cP<0.001)
FIGURE 12 CYP1A activity induced by individual and combined
AFB1 and FB1 in BRL-3A cells at 24 h. Letters indicate the diﬀer-
ences from the control (aP<0.05, cP<0.001)
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fact have been related to several factors, including dose and time of
incubation, as well as the intrinsic susceptibility of BRL-3A cells to its
toxicity, with all of these contributing to some extent to an eﬃciently
scavenged slight rise in ROS, to an eﬀective DNA repair, or to both.
Genetic alterations can lead to cell cycle arrest, death, or malignant
transformation, depending on the lesion severity, cell type, and cellular
context.30 Inhibition of the cell cycle progression in the G1 phase is
largely dependent on the activation of the p53 tumor suppressor
gene,50 which may be an adaptive survival process activated to give
additional time for DNA repair and to limit the mutations that might
arise when replicating damaged genetic material. Alternatively, G1-
phase arrest can lead to apoptosis activation.51 In this study, the block-
ing in the G1- to S-phase transition, which was correlated to higher
expression of p53, might be revealing a cell ﬁrst attempt to repair gen-
otoxic lesions caused by the mycotoxin mixture. Later, a severely dam-
aged DNA probably exceeding the repair capacities in cells treated
with the mycotoxin mixture may have led to membrane depolarization
and apoptosis, which plays a crucial role in maintaining genomic integ-
rity by selectively removing the most heavily impaired cells from the
population.30 Despite it was previously reported that FB1 prevented
the mitochondrial membrane depolarization in human gastric cancer
MGC-803 cells52 and in rat primary retinal cultures53; in this work, the
oxidative stress induced by the mycotoxin combination could be
responsible by the mitochondrial membrane depolarization that leads
to cell apoptosis. The exposure of BRL-3A cells to AFB1 and FB1 indi-
vidually did lead neither to mitochondrial membrane depolarization nor
to cell death, potentially due to nonlethal DNA damage at least partially
reverted within the G1-phase arrest induced by the mycotoxins indi-
vidually. The results of this study are in line with previous ones
informed by Sun et al.,37 who have shown that under similar experi-
mental conditions, AFB1 and FB1 individually did not alter the BRL-3A
cell viability. Moreover, jointly they could be indicating a relatively
higher resistance of these hepatic cells to the toxins, as other authors
demonstrated that AFB1 and FB1 alone can induce cell death in several
cell types.27,29
In this work, the oxidative stress was partially responsible for the
hepatotoxic eﬀects stimulated by AFB1 either alone or combined with
FB1 (but not that induced by the individual FB1), since NAC pretreat-
ment of BRL-3A hepatocytes could only attenuate the blocking of cell
cycle progression in the treatments with AFB1 and the mycotoxin mix-
ture. Oxidative hepatotoxicity may have been produced because an
aberrant increase of ROS altered the signaling pathways that modulate
the expression of genes such as p53 and others involved in the activa-
tion of cell cycle control points and apoptosis.31,54The results of this
work support the hypothesis of Ricordy et al.,28 who postulated that
the toxic eﬀect of AFB1 on cell cycle progression may be related to dif-
ferences in p53 expression, arresting it when a slight DNA damage lets
a functional p53 protein synthesis (AFB1 alone, this work), or inducing
cell death in the case of an aberrant gene expression due to extensive
genetic damage (AFB11FB1, this work). Moreover, cell cycle arrest
and cell death remaining in cells treated with AFB1 and NAC may be
associated with the direct genotoxicity of this toxin.
As AFB1 and the mixture, FB1 increased the expression of p53 and
caused G1 to S-phase blocking although in an oxidative-stress-
independent way. This regulatory protein was probably involved in the
cell cycle arrest induced by FB1; however, the modulated expression
and/or activity of some proteins involved in the G1/S checkpoint (such
as p21; Cyclin E; Cyclin dependent kinase 2, CDK2; and CDK inhibi-
tors) by this fumonisin might have been involved in such outcome.55
The already well-documented perturbations of the sphingolipid metab-
olism produced by this toxin20 could mediate such eﬀects, as sphingoid
base signaling is involved in cell cycle control.56,57 Nevertheless, the
chronological and diﬀerential expression of genes controlling cell cycle
progression upon exposure to the individually or mixed AFB1 and FB1
remains to be explored in depth.
Similar to the observations about the cytotoxic and genotoxic
eﬀects, the results from this study suggest a possible synergistic inter-
action of the toxins to induce oxidative stress. In cells exposed to the
AFB1–FB1 mixture, this was characterized by an increased oxidation of
proteins and lipids, which in turn was correlated with higher accumula-
tions of O·22 and total ROS, mainly generated by CYP complex activa-
tion and increased ArAc metabolism. This treatment also stimulated
catalase activity probably as a compensatory mechanism of the
increased H2O2 and lipid peroxides, which are reactive species that
induce the antioxidant enzyme expression.58
The results of this work may also indicate a major contribution of
AFB1 to the pro-oxidant activity of the mycotoxin mixture, because cell
treatment with this aﬂatoxin alone also increased lipid oxidation and
total ROS content, whose biochemical sources were both the increased
CYP activity and the ArAc metabolism. Supporting this, the relative
DCF ﬂuorescence intensities, a widely used indicator of total ROS con-
tent, were 2.25-, 1.67-, and 1.19-fold greater than control in BRL-3A
hepatocytes treated with the mixture, AFB1 and FB1, respectively, with
even the major ROS sources induced by this fumonisin being diﬀerent
than the ones tested in this study. Furthermore, the rise in RNS
observed in cells incubated with the both toxin mixture was also stimu-
lated by AFB1 alone, but not by the FB1 treatment. However, it is prob-
able that the contribution of these reactive species to biomolecule
oxidation as well as the cytotoxic and genotoxic eﬀects studied is not
relevant due to the low cell percentage that increased RNS production
(about 10%, for treatments with individual AFB1 and the mixture), com-
pared to that increasing total ROS production (about 45% and 70% for
treatments with AFB1 single and in combination with FB1, respec-
tively). In addition, the lack of interactive eﬀect between the toxins in
RNS generation is not correlated with the mycotoxin interaction to
induce hepatotoxicity, suggesting a scarce or null RNS contribution to
such toxicity.
The single mycotoxins were not eﬀective at evoking the protein
carbonyl increase produced by their mixture. In fact, the oxidative
stress induced by these toxins would stimulate proteasome-dependent
degradation of oxidized proteins, thus decreasing protein carbonyl to
basal levels. Notwithstanding, a more severe oxidative stress triggered
by the mycotoxin mixture could provoke extensive oxidation, thereby
generating cross-linked and aggregated proteins that become resistant
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to proteolysis and cause accumulation of cytotoxic protein oxidation
products.59,60 Excessive protein oxidation may also have a wide range
of functional consequences, such as inactivation of DNA repair enzymes,
loss of DNA polymerase ﬁdelity and modiﬁcation of the protein activity
involved in proliferation, cell cycle and death, which may promote geno-
toxicity and carcinogenicity.61 Favoring such outcomes, the lipid peroxi-
dation caused mainly by the mixture, but also by the individual
mycotoxins, probably contributes to their genotoxic and cytotoxic
eﬀects. Some lipid peroxidation products, such as MDA and 4-
hydroxynonenal (4-HNE), which are generated by the nonenzymatic or
enzymatic decomposition of ArAc and larger PUFAs,62 can covalently
react with DNA, proteins, and lipids, thus leading to DNA strand breaks,
mutations, loss of membrane ﬂuidity, cell cycle arrest, and apoptosis.63,64
Nevertheless, a major contribution of the lipid peroxidation to the geno-
toxicity and cytotoxicity of the mycotoxin mixture would be expected,
owing to the greater ArAc metabolism induced by this treatment.
In this work AFB1 alone, and especially combined with FB1,
increased the activity of PLA and CYP1A, being the latter in agreement
with previous results published by Mary et al.25 The interactive eﬀects of
the AFB1–FB1 mixture on the CYP activity and ArAc metabolism induc-
tion may have been associated with the higher oxidative stress caused by
the combined action of both mycotoxins, with the data indicating the
nuclear transcription factor aryl hydrocarbon receptor (AhR) as being the
probable mediator of such actions. Recently, Mary et al.25 postulated that
AFB1 is an AhR agonist, as it increased the CYP1A activity and cyp1A
transcription in the H4IIE rat hepatoma cell line, which was associated
with an enhanced AhR activity (a primary regulator of cyp1A expression)
in DR-CALUX cell line. Moreover, the induction of other CYP subfamilies
such as 3A by AFB1
65 and FB1,
24 as well as the AFB1 metabolization itself
by CYP, might also contribute to the higher activity of this enzyme com-
plex and consequent ROS generation. On the other hand, the increased
ArAc metabolism could be secondary to a major PLA2 expression caused
by toxin-stimulated AhR signaling, as previous genome microarray and
real-time quantitative RT-PCR studies have demonstrated increased
PLA2 mRNA levels upon AhR activation in mouse liver and hepatoma
Hepa-1c1c7 cells.66,67 Taken together, the preceding data suggest that
the stronger induction eﬀect of the AFB1–FB1 mixture on the metabolic
pathways studied in this study was probably provoked by a higher AhR
activation, similarly to that observed in hepatic H4IIE cells.25
In summary, the results presented in this work show that exposure
to the AFB1–FB1 mixture increased the ArAc metabolism and CYP
activity in BRL-3A hepatocytes, leading to higher ROS synthesis and
subsequent stronger oxidative biomolecular damage. Furthermore, this
study strongly suggests that the AFB1–FB1 mixture could be raising
the AFBO generation by the increased activity of such AFB1 metaboliz-
ing pathways. Together, the enhanced AFB1 bioactivation and the
induction of a greater oxidative stress, may promote genotoxicity and
cell cycle alteration, therefore conferring a higher hepatocarcinogenic
potential to the AFB1–FB1 mixture.
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